Posted inBiotechnology
Chloride Ions Become Unexpected Allies in Solar-Powered Seawater Hydrogen Production
For decades, the salt in seawater has been the villain of solar hydrogen research. Chloride ions corrode electrodes, compete with…
Posted inBiotechnology
Living Fossil Quillworts Reveal How Mutation and Selection Sculpt Ancient Chloroplast Genomes
The quillwort genus Isoetes is one of the strangest survivors in the plant kingdom. Resembling a tuft of leek-like blades…
Posted inBiotechnology
Certifying Electric Flight: Why the Toughest Challenge in Zero-Emission Aviation Is Proving It Is Safe
Electric and hybrid-electric propulsion has moved from the margins of aerospace research to the center of the industry’s plan for…
Posted inBiotechnology
Massive Apple Tree Image Dataset Aims to Teach AI How Orchards Grow
A team of European researchers has unveiled one of the most extensive annotated image collections ever assembled for apple tree…
Posted inBiotechnology
Blood Proteins and Metabolites Tracked Over a Decade Reveal New Drivers of Metabolic Health
Scientists have long known that the blood carries a wealth of information about human health, but most studies have examined…
Posted inBiotechnology
Ancient Viral Fossils in Tumors Reveal Targets That Drive Anti-Metastatic Immunity in Breast Cancer
Endogenous retroviruses, the molecular remnants of ancient viral infections that have been embedded in the genomes of mammals for millions…
Posted inBiotechnology
Orphaned Cheetahs Raised by Humans Tune Out Their Own Species’ Calls
Cheetahs that lose their mothers in the first weeks of life and are then raised by human caretakers may carry…
Posted inBiotechnology
Bioplastic from Sugarcane Waste: Scientists Perfect the Math of Microbial PHB Production
Biodegradable plastics made by bacteria have long promised to replace petroleum-based polyethylene and polypropylene, yet the economics of producing them…
Posted inBiotechnology
Beacon lights path to FDA approval with pivotal trial win for rare vision loss gene therapy
Beacon Therapeutics has found the light in a rare vision loss disease that has left larger companies in the dark.…
Posted inGenetics
Lilly’s GIP/GLP-1 Candidate Brenipatide Shows Early Clinical Promise in Substance, Psych Disorders
Eli Lilly researchers at work. Lilly on Friday presented early positive clinical data supporting once-weekly dosing for its GIP/GLP-1 receptor…